Endothelin receptor antagonists in proteinuric renal disease: every rose has its thorn
- PMID: 20133487
- PMCID: PMC4473251
- DOI: 10.1681/ASN.2010010047
Endothelin receptor antagonists in proteinuric renal disease: every rose has its thorn
Comment on
-
Avosentan reduces albumin excretion in diabetics with macroalbuminuria.J Am Soc Nephrol. 2009 Mar;20(3):655-64. doi: 10.1681/ASN.2008050482. Epub 2009 Jan 14. J Am Soc Nephrol. 2009. PMID: 19144760 Free PMC article. Clinical Trial.
-
Avosentan for overt diabetic nephropathy.J Am Soc Nephrol. 2010 Mar;21(3):527-35. doi: 10.1681/ASN.2009060593. Epub 2010 Feb 18. J Am Soc Nephrol. 2010. PMID: 20167702 Free PMC article. Clinical Trial.
References
-
- Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988 - PubMed
-
- Lehrke I, Waldherr R, Ritz E, Wagner J: Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria. J Am Soc Nephrol 12: 2321–2329, 2001 - PubMed
-
- Ge Y, Bagnall A, Stricklett PK, Strait K, Webb DJ, Kotelevtsev Y, Kohan DE: Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol 291: F1274–F1280, 2006 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
